(6S)-dehydrovomifoliol

Metabolite details

Identifier

JJRYPZMXNLLZFH-URWSZGRFSA-N

InChI Key

JJRYPZMXNLLZFH-URWSZGRFSA-N

IUPAC name

(4S)-4-hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxobut-1-en-1-yl]cyclohex-2-en-1-one

Preferred name

(6S)-dehydrovomifoliol

INN name

—

Synonym

(4S)-4-hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxobut-1-enyl]cyclohex-2-en-1-one

ChEBI

CHEBI:4372

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Disturbed Microbiota-Metabolites-Immune Interaction Network is Associated with Olfactory Dysfunction in Patients with Chronic Rhinosinusitis

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Control_vs_Exercise
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose
• Normal_vs_Abnormal